You searched for
We found 9 articles
GALLANT 22 Tesaglitazar Vs. Placebo in Patients with Type 2 Diabetes
This is a 24-week randomized, double-blind, parallel-group, multi-center, placebo-controlled study of tesaglitazar (0.5 and 1 mg) in patients with type…
01 Jan 2013
Study Evaluating PPM-204 In Subjects With Type 2 Diabetes
The purpose of this study is to learn whether PPM-204 has an effect on lowering blood glucose (blood sugar) levels…
01 Jan 2013
E.V.O.L.V.E. Trial: EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events
This study will evaluate the effects of cinacalcet (cincalcet HCl or Sensipar/Mimpara) on cardiovascular events and death in chronic kidney…
01 Jan 2013
A Study to Investigate the Effect of Rosuvastatin (CRESTOR) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome
The purpose of this study is to investigate the dose-related effect of treatment with rosuvastatin on production and fractional catabolism…
01 Jan 2013
Trial to Reduce Cardiovascular Events With ‘Aranesp’ Therapy (TREAT)
The purpose of this study is to assess the impact of treatment of anemia with darbepoetin alfa on mortality and…
01 Jan 2013
A Comparison of AZD6140 and Clopidogrel in Patients With Acute Coronary Syndrome
AZD6140 is a new, reversible, anti-platelet medication. Anti-platelet medications work to prevent the formation of blood clots. AZD6140 is being…
01 Jan 2013
A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)
The purpose of this study is to see if 40 mg of rosuvastatin taken daily will reduce the atherosclerosis (fatty…
01 Jan 2013
Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke (SPARCL)
To determine whether Lipitor reduces stroke, compared to placebo in patients who have had a previous stroke or transient ischemic…
01 Jan 2013
FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)
This study is an international, multi-center, randomized, double-blind, placebo-controlled study in subjects with PAH who are currently receiving approved therapy…
01 Jan 2013
